Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ABBV
ABBV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABBV News
FDA Approves Linzess Label Expansion for Children
2d ago
seekingalpha
Obesity Drug Market Poised for Growth
4d ago
Fool
Weight Loss Drug Market Poised for Growth
4d ago
NASDAQ.COM
Dividend Investment Analysis: AbbVie vs. Pfizer
5d ago
Fool
Dividend Comparison: Pfizer vs AbbVie
5d ago
NASDAQ.COM
Warren Buffett's Long-Term Investment Advice
5d ago
Fool
AbbVie and Two Dividend Kings Show Strong Prospects
5d ago
NASDAQ.COM
Three Dividend Growth Stocks to Consider Amid Market Uncertainty
May 23 2026
Fool
Three High-Yield Dividend Stocks to Consider
May 23 2026
NASDAQ.COM
Investors Shift Focus to High-Yield Dividend Stocks
May 23 2026
Yahoo Finance
Healthcare Stocks Surge Due to Innovation and Policy Changes
May 22 2026
NASDAQ.COM
Healthcare Sector Sees Best Week in Six Months
May 22 2026
Fool
AbbVie's MAVIRET Receives Positive EMA Opinion for Hepatitis C Treatment
May 22 2026
NASDAQ.COM
AbbVie Receives Positive EMA Opinion for MAVIRET in Acute Hepatitis C Treatment
May 22 2026
PRnewswire
AbbVie’s MAVIRET Receives Positive Opinion for Acute Hepatitis C Treatment
May 22 2026
Newsfilter
AbbVie: A Top Pick in Uncertain Markets
May 22 2026
Fool
Show More News
